This presentation will review FDA approved long-acting injectable buprenorphine products with an emphasis on operational and clinical considerations. Dosing strategies, patient counseling pearls, administration techniques, REMS compliance, and common adverse effects will be discussed. After attending this presentation, attendees should be comfortable developing a treatment plan that incorporates long-acting injectable buprenorphine for the treatment of opioid use disorders.

As a result of attending this session, attendees will be able to:

1. Identify key operational considerations when introducing long-acting injectable buprenorphine products into a practice; and,

2. Identify indications, contraindications, and adverse effects of long-acting injectable buprenorphine and discuss key clinical considerations when selecting a long-acting injectable buprenorphine product.